|
Volumn 47, Issue SUPPL. 1, 2001, Pages 1-4
|
Chemotherapy: Introduction
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
CEPHALOSPORIN DERIVATIVE;
LEVOFLOXACIN;
MACROLIDE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ANTIINFECTIVE AGENT;
QUINOLONE DERIVATIVE;
ANTIBIOTIC THERAPY;
ARGENTINA;
CONFERENCE PAPER;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
INFECTION;
ITALY;
OUTPATIENT CARE;
PRIORITY JOURNAL;
UNITED KINGDOM;
UNITED STATES;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
SIDE EFFECT;
ARTICLE;
CHEMISTRY;
CLINICAL TRIAL;
DRUG DESIGN;
DRUG TOLERANCE;
STRUCTURE ACTIVITY RELATION;
ANTI-INFECTIVE AGENTS;
CLINICAL TRIALS;
DRUG DESIGN;
DRUG TOLERANCE;
FLUOROQUINOLONES;
HUMANS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0035218130
PISSN: 00093157
EISSN: None
Source Type: Journal
DOI: 10.1159/000048562 Document Type: Conference Paper |
Times cited : (4)
|
References (14)
|